Tumor virology

Tumor virology manages the particular infection diseases and malignancy, oncogenes, tumor silencers, oncogenic cofactors, disturbance of natural/versatile resistant reactions, inertness, viral mimicry/robbery of cell administrative qualities, genomic unsteadiness and part of non-coding RNAs in viral pathogenesis. The motivation behind this investigation is to create viral vectors for human growth quality treatment and to advance immunization procedures for treatment of viral-related malignancies. A few techniques are being trailed incorporating hereditary inoculation with recombinant viral vectors in view of Semliki Forest infection, insusceptible checkpoint inhibitors and methodologies to re-balance the immuno suppressive tumor condition.

  • Viral Mimicry of genes
  • Principle investigator
  • Viral Therapy
  • Viral-associated Cancers

Related Conference of Tumor virology

March 18-19, 2024

5th Global Summit on Oncology and Hematology

Zurich, Switzerland
June 10-11, 2024

8th Global Meeting on Oncology and Radiology

Barcelona, Spain
July 11-12, 2024

24th World Congress on Cancer and Diagnostics

Vancouver, Canada
July 18-19, 2024

14th World Congress on Breast Cancer

Paris, France
September 19-20, 2024

25th World Congress on Cancer Summit

Paris, France

Tumor virology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in